(Q35009369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Yinyin Yuan

series ordinal

1

1 reference

PubMed publication ID

25505134

5 August 2017

publication date

1 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Royal Society Interface

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas

25 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Combat or surveillance? Evaluation of the heterogeneous inflammatory breast cancer microenvironment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Comprehensive molecular portraits of human breast tumours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

The immune contexture in human tumours: impact on clinical outcome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

A signature of immune function genes associated with recurrence-free survival in breast cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

KEGG: kyoto encyclopedia of genes and genomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

8 July 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

Computerized image-based detection and grading of lymphocytic infiltration in HER2+ breast cancer histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

Estimating the Dimension of a Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

APOBEC3B mutagenesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

A TEST OF SIGNIFICANCE FOR THE RELATION BETWEEN m RANKINGS AND k RANKED CATEGORIES

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSIF.2014.1153

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

New insights of CTLA-4 into its biological function in breast cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305416

26 October 2018

Identifiers

DOI

10.1098/RSIF.2014.1153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

PubMed publication ID

25505134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25505134%20AND%20SRC:MED&resulttype=core&format=json